VANGUARD GROUP INC

Holdings History for SpringWorks Therapeutics, Inc. - Common Stock, par value $0.0001 per share (SWTX)

Symbol: SWTX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 7.16M shares
Security Ownership: 9.62%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in SpringWorks Therapeutics, Inc. Common Stock, par value $0.0001 per share (SWTX)

2025-01-31 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.16M shares of SpringWorks Therapeutics, Inc. Common Stock, par value $0.0001 per share (SWTX). This represents 9.62% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	9.62%		$316M	7.16M			$44.13	13G/A	12/31/2024	31 Jan 2025 09:55:50

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0%	+0%	$259M	7.16M	+445,593	+6.64%	$36.13	Q4 2024
9/30/2024	0%	+0%	$215M	6.71M	+168,865	+2.58%	$32.04	Q3 2024
6/30/2024	0%	+0%	$247M	6.54M	+15,088	+0.23%	$37.67	Q2 2024
3/31/2024	0.01%	+0%	$321M	6.53M	+492,783	+8.16%	$49.22	Q1 2024
12/31/2023	0%	+0%	$220M	6.04M	+1,114,080	+22.6%	$36.50	Q4 2023
9/30/2023	0%	+0%	$114M	4.92M	+20,651	+0.42%	$23.12	Q3 2023
6/30/2023	0%	+0%	$129M	4.9M	+493,284	+11.2%	$26.22	Q2 2023
3/31/2023	0%	+0%	$113M	4.41M	+86,172	+1.99%	$25.74	Q1 2023
12/31/2022	0%	+0%	$112M	4.32M	+1,126,310	+35.2%	$26.01	Q4 2022
9/30/2022	0%	+0%	$91.2M	3.2M	+451,928	+16.5%	$28.53	Q3 2022
6/30/2022	0%	0%	$67.6M	2.74M	-136,869	-4.75%	$24.62	Q2 2022
3/31/2022	0%	+0%	$163M	2.88M	+18,674	+0.65%	$56.44	Q1 2022
12/31/2021	0%		$177M	2.86M	+154	+0.01%	$61.98	Q4 2021
9/30/2021	0%	+0%	$182M	2.86M	+156,091	+5.77%	$63.44	Q3 2021
6/30/2021	0.01%	+0%	$223M	2.71M	+212,011	+8.5%	$82.41	Q2 2021
3/31/2021	0%	+0%	$183M	2.49M	+1,222,911	+96.2%	$73.57	Q1 2021
12/31/2020	0%	+0%	$92.2M	1.27M	+589,143	+86.4%	$72.52	Q4 2020
9/30/2020	0%	+0%	$32.5M	682K	+140,847	+26%	$47.67	Q3 2020
6/30/2020	0%	+0%	$22.7M	541K	+88,742	+19.6%	$42.00	Q2 2020
3/31/2020	0%	+0%	$12.2M	452K	+62,857	+16.1%	$27.00	Q1 2020
12/31/2019	0%	+0%	$15M	390K	+319,556	+457%	$38.49	Q4 2019
9/30/2019	0%	+0%	$1.52M	70K	+70,000	NEW	$21.69	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.